sales@reportsmonitor.com
  • +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Biologics and Biosimilars Market

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biologics and Biosimilars Market 2018, Forecast to 2023


A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

Scope of the Report:
This report focuses on the Biologics and Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

The worldwide market for Biologics and Biosimilars is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 199600 million US$ in 2023, from 144700 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck
    3sbio
    Changchun High Tech
    CP Guojian
    Biotech
    Gelgen
    Innovent
    Dong Bao
    Ganlee
    United Laboratories
    Others

Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Antibody
    Hormone
    Growth Factors
    Other

Market Segment by Applications, can be divided into
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other

There are 15 Chapters to deeply display the global Biologics and Biosimilars market.
Chapter 1, to describe Biologics and Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biologics and Biosimilars, with sales, revenue, and price of Biologics and Biosimilars, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologics and Biosimilars, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source	
Table of Contents

1 Market Overview
    1.1 Biologics and Biosimilars Introduction
    1.2 Market Analysis by Type
        1.2.1 Antibody
        1.2.2 Hormone
        1.2.3 Growth Factors
        1.2.4 Other
    1.3 Market Analysis by Applications
        1.3.1 Tumor
        1.3.2 Diabetes
        1.3.3 Cardiovascular
        1.3.4 Hemophilia
        1.3.5 Other
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2013-2023)
            1.4.1.2 Canada Market States and Outlook (2013-2023)
            1.4.1.3 Mexico Market States and Outlook (2013-2023)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2013-2023)
            1.4.2.2 France Market States and Outlook (2013-2023)
            1.4.2.3 UK Market States and Outlook (2013-2023)
            1.4.2.4 Russia Market States and Outlook (2013-2023)
            1.4.2.5 Italy Market States and Outlook (2013-2023)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2013-2023)
            1.4.3.2 Japan Market States and Outlook (2013-2023)
            1.4.3.3 Korea Market States and Outlook (2013-2023)
            1.4.3.4 India Market States and Outlook (2013-2023)
            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2013-2023)
            1.4.4.2 Egypt Market States and Outlook (2013-2023)
            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
            1.4.4.4 South Africa Market States and Outlook (2013-2023)
            1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Business Overview
            2.1.1.1 Roche Description
            2.1.1.2 Roche Headquarter, Main Business and Finance Overview
        2.1.2 Roche Biologics and Biosimilars Product Introduction
            2.1.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.1.2.2 Biologics and Biosimilars Product Information
        2.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.1.3.1 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.1.3.2 Global Roche Biologics and Biosimilars Market Share in 2017
    2.2 Amgen
        2.2.1 Business Overview
            2.2.1.1 Amgen Description
            2.2.1.2 Amgen Headquarter, Main Business and Finance Overview
        2.2.2 Amgen Biologics and Biosimilars Product Introduction
            2.2.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.2.2.2 Biologics and Biosimilars Product Information
        2.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.2.3.1 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.2.3.2 Global Amgen Biologics and Biosimilars Market Share in 2017
    2.3 AbbVie
        2.3.1 Business Overview
            2.3.1.1 AbbVie Description
            2.3.1.2 AbbVie Headquarter, Main Business and Finance Overview
        2.3.2 AbbVie Biologics and Biosimilars Product Introduction
            2.3.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.3.2.2 Biologics and Biosimilars Product Information
        2.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.3.3.1 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.3.3.2 Global AbbVie Biologics and Biosimilars Market Share in 2017
    2.4 Sanofi-Aventis
        2.4.1 Business Overview
            2.4.1.1 Sanofi-Aventis Description
            2.4.1.2 Sanofi-Aventis Headquarter, Main Business and Finance Overview
        2.4.2 Sanofi-Aventis Biologics and Biosimilars Product Introduction
            2.4.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.4.2.2 Biologics and Biosimilars Product Information
        2.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.4.3.1 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.4.3.2 Global Sanofi-Aventis Biologics and Biosimilars Market Share in 2017
    2.5 Johnson & Johnson
        2.5.1 Business Overview
            2.5.1.1 Johnson & Johnson Description
            2.5.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
        2.5.2 Johnson & Johnson Biologics and Biosimilars Product Introduction
            2.5.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.5.2.2 Biologics and Biosimilars Product Information
        2.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.5.3.1 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.5.3.2 Global Johnson & Johnson Biologics and Biosimilars Market Share in 2017
    2.6 Pfizer
        2.6.1 Business Overview
            2.6.1.1 Pfizer Description
            2.6.1.2 Pfizer Headquarter, Main Business and Finance Overview
        2.6.2 Pfizer Biologics and Biosimilars Product Introduction
            2.6.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.6.2.2 Biologics and Biosimilars Product Information
        2.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.6.3.1 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.6.3.2 Global Pfizer Biologics and Biosimilars Market Share in 2017
    2.7 Novo Nordisk
        2.7.1 Business Overview
            2.7.1.1 Novo Nordisk Description
            2.7.1.2 Novo Nordisk Headquarter, Main Business and Finance Overview
        2.7.2 Novo Nordisk Biologics and Biosimilars Product Introduction
            2.7.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.7.2.2 Biologics and Biosimilars Product Information
        2.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.7.3.1 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.7.3.2 Global Novo Nordisk Biologics and Biosimilars Market Share in 2017
    2.8 Eli Lilly
        2.8.1 Business Overview
            2.8.1.1 Eli Lilly Description
            2.8.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
        2.8.2 Eli Lilly Biologics and Biosimilars Product Introduction
            2.8.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.8.2.2 Biologics and Biosimilars Product Information
        2.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.8.3.1 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.8.3.2 Global Eli Lilly Biologics and Biosimilars Market Share in 2017
    2.9 Novartis
        2.9.1 Business Overview
            2.9.1.1 Novartis Description
            2.9.1.2 Novartis Headquarter, Main Business and Finance Overview
        2.9.2 Novartis Biologics and Biosimilars Product Introduction
            2.9.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.9.2.2 Biologics and Biosimilars Product Information
        2.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.9.3.1 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.9.3.2 Global Novartis Biologics and Biosimilars Market Share in 2017
    2.10 Merck
        2.10.1 Business Overview
            2.10.1.1 Merck Description
            2.10.1.2 Merck Headquarter, Main Business and Finance Overview
        2.10.2 Merck Biologics and Biosimilars Product Introduction
            2.10.2.1 Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
            2.10.2.2 Biologics and Biosimilars Product Information
        2.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.10.3.1 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
            2.10.3.2 Global Merck Biologics and Biosimilars Market Share in 2017
    2.11 3sbio
        2.11.1 Business Overview
        2.11.2 3sbio Biologics and Biosimilars Product Introduction
        2.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Changchun High Tech
        2.12.1 Business Overview
        2.12.2 Changchun High Tech Biologics and Biosimilars Product Introduction
        2.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13 CP Guojian
        2.13.1 Business Overview
        2.13.2 CP Guojian Biologics and Biosimilars Product Introduction
        2.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.14 Biotech
        2.14.1 Business Overview
        2.14.2 Biotech Biologics and Biosimilars Product Introduction
        2.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.15 Gelgen
        2.15.1 Business Overview
        2.15.2 Gelgen Biologics and Biosimilars Product Introduction
        2.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.16 Innovent
        2.16.1 Business Overview
        2.16.2 Innovent Biologics and Biosimilars Product Introduction
        2.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.17 Dong Bao
        2.17.1 Business Overview
        2.17.2 Dong Bao Biologics and Biosimilars Product Introduction
        2.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.18 Ganlee
        2.18.1 Business Overview
        2.18.2 Ganlee Biologics and Biosimilars Product Introduction
        2.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.19 United Laboratories
        2.19.1 Business Overview
        2.19.2 United Laboratories Biologics and Biosimilars Product Introduction
        2.19.3 United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.20 Others
        2.20.1 Business Overview
        2.20.2 Others Biologics and Biosimilars Product Introduction
        2.20.3 Others Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologics and Biosimilars Market Competition, by Manufacturer
    3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2016-2017)
    3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Global Biologics and Biosimilars Price by Manufacturer (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2017
        3.4.2 Top 5 Biologics and Biosimilars Manufacturer Market Share in 2017
    3.5 Market Competition Trend
4 Global Biologics and Biosimilars Market Analysis by Regions
    4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
        4.1.1 Global Biologics and Biosimilars Sales by Regions (2013-2018)
        4.1.2 Global Biologics and Biosimilars Revenue by Regions (2013-2018)
    4.2 North America Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
    4.3 Europe Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
    4.4 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
    4.5 South America Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
    4.6 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Growth Rate (2013-2018)
5 North America Biologics and Biosimilars by Countries, Type, Application and Manufacturers
    5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        5.1.1 North America Biologics and Biosimilars Sales by Countries (2013-2018)
        5.1.2 North America Biologics and Biosimilars Revenue by Countries (2013-2018)
        5.1.3 United States Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        5.1.4 Canada Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        5.1.5 Mexico Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    5.2 North America Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
        5.2.1 North America Biologics and Biosimilars Sales by Manufacturers (2016-2017)
        5.2.2 North America Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
    5.3 North America Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
        5.3.1 North America Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
        5.3.2 North America Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
    5.4 North America Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
        5.4.1 North America Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
        5.4.2 North America Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
6 Europe Biologics and Biosimilars by Countries, Type, Application and Manufacturers
    6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        6.1.1 Europe Biologics and Biosimilars Sales by Countries (2013-2018)
        6.1.2 Europe Biologics and Biosimilars Revenue by Countries (2013-2018)
        6.1.3 Germany Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        6.1.4 UK Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        6.1.5 France Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        6.1.6 Russia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        6.1.7 Italy Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    6.2 Europe Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
        6.2.1 Europe Biologics and Biosimilars Sales by Manufacturers (2016-2017)
        6.2.2 Europe Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
    6.3 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
        6.3.1 Europe Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
        6.3.2 Europe Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
    6.4 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
        6.4.1 Europe Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
        6.4.2 Europe Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Biologics and Biosimilars by Countries, Type,  Application and Manufacturers
    7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Biologics and Biosimilars Sales by Countries (2013-2018)
        7.1.2 Asia-Pacific Biologics and Biosimilars Revenue by Countries (2013-2018)
        7.1.3 China Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        7.1.4 Japan Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        7.1.5 Korea Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        7.1.6 India Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        7.1.7 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    7.2 Asia-Pacific Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
        7.2.1 Asia-Pacific Biologics and Biosimilars Sales by Manufacturers (2016-2017)
        7.2.2 Asia-Pacific Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
    7.3 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
        7.3.1 Asia-Pacific Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
        7.3.2 Asia-Pacific Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
    7.4 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
        7.4.1 Asia-Pacific Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
        7.4.2 Asia-Pacific Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
8 South America Biologics and Biosimilars by Countries, Type, Application and Manufacturers
    8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        8.1.1 South America Biologics and Biosimilars Sales by Countries (2013-2018)
        8.1.2 South America Biologics and Biosimilars Revenue by Countries (2013-2018)
        8.1.3 Brazil Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        8.1.4 Argentina Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        8.1.5 Colombia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    8.2 South America Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
        8.2.1 South America Biologics and Biosimilars Sales by Manufacturers (2016-2017)
        8.2.2 South America Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
    8.3 South America Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
        8.3.1 South America Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
        8.3.2 South America Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
    8.4 South America Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
        8.4.1 South America Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
        8.4.2 South America Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Biologics and Biosimilars by Countries, Type, Application and Manufacturers
    9.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Biologics and Biosimilars Sales by Countries (2013-2018)
        9.1.2 Middle East and Africa Biologics and Biosimilars Revenue by Countries (2013-2018)
        9.1.3 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        9.1.4 UAE Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        9.1.5 Egypt Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        9.1.6 Nigeria Biologics and Biosimilars Sales and Growth Rate (2013-2018)
        9.1.7 South Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    9.2 Middle East and Africa Biologics and Biosimilars Sales and Revenue (Value) by Manufacturers (2016-2017)
        9.2.1 Middle East and Africa Biologics and Biosimilars Sales by Manufacturers (2016-2017)
        9.2.2 Middle East and Africa Biologics and Biosimilars Revenue by Manufacturers (2016-2017)
    9.3 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
        9.3.1 Middle East and Africa Biologics and Biosimilars Sales and Sales Share by Type (2013-2018)
        9.3.1 Middle East and Africa Biologics and Biosimilars Revenue and Revenue Share by Type (2013-2018)
    9.4 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Application (2013-2018)
        9.4.1 Middle East and Africa Biologics and Biosimilars Sales and Sales Share by Application (2013-2018)
        9.4.2 Middle East and Africa Biologics and Biosimilars Revenue and Revenue Share by Application (2013-2018)
10 Global Biologics and Biosimilars Market Segment by Type
    10.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
        10.1.1 Global Biologics and Biosimilars Sales and Market Share by Type (2013-2018)
        10.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
    10.2 Antibody Sales Growth and Price
        10.2.1 Global Antibody Sales Growth (2013-2018)
        10.2.2 Global Antibody Price (2013-2018)
    10.3 Hormone Sales Growth and Price
        10.3.1 Global Hormone Sales Growth (2013-2018)
        10.3.2 Global Hormone Price (2013-2018)
    10.4 Growth Factors Sales Growth and Price
        10.4.1 Global Growth Factors Sales Growth (2013-2018)
        10.4.2 Global Growth Factors Price (2013-2018)
    10.5 Other Sales Growth and Price
        10.5.1 Global Other Sales Growth (2013-2018)
        10.5.2 Global Other Price (2013-2018)
11 Global Biologics and Biosimilars Market Segment by Application
    11.1 Global Biologics and Biosimilars Sales Market Share by Application (2013-2018)
    11.2 Tumor Sales Growth (2013-2018)
    11.3 Diabetes Sales Growth (2013-2018)
    11.4 Cardiovascular Sales Growth (2013-2018)
    11.5 Hemophilia Sales Growth (2013-2018)
    11.6 Other Sales Growth (2013-2018)
12 Biologics and Biosimilars Market Forecast (2018-2023)
    12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2018-2023)
    12.2 Biologics and Biosimilars Market Forecast by Regions (2018-2023)
        12.2.1 North America Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.2 Europe Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.4 South America Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.5 Middle East and Africa Biologics and Biosimilars Market Forecast (2018-2023)
    12.3 Biologics and Biosimilars Market Forecast by Type (2018-2023)
        12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2018-2023)
        12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2018-2023)
    12.4 Biologics and Biosimilars Market Forecast by Application (2018-2023)
        12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2018-2023)
        12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

	List of Tables and Figures

Figure Biologics and Biosimilars Picture
Table Product Specifications of Biologics and Biosimilars
Figure Global Biologics and Biosimilars CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Biologics and Biosimilars CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Biologics and Biosimilars by Types in 2017
Figure Antibody Picture
Table Major Manufacturers of Antibody
Figure Hormone Picture
Table Major Manufacturers of Hormone
Figure Growth Factors Picture
Table Major Manufacturers of Growth Factors
Figure Other Picture
Table Major Manufacturers of Other
Figure Biologics and Biosimilars Sales Market Share by Applications in 2017
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Figure United States Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure France Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure China Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure India Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Roche Biologics and Biosimilars Product
Table Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Biologics and Biosimilars Sales Market Share in 2017
Figure Global Roche Biologics and Biosimilars Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Amgen Biologics and Biosimilars Product
Table Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Biologics and Biosimilars Sales Market Share in 2017
Figure Global Amgen Biologics and Biosimilars Revenue Market Share in 2017
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table AbbVie Biologics and Biosimilars Product
Table AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Biologics and Biosimilars Sales Market Share in 2017
Figure Global AbbVie Biologics and Biosimilars Revenue Market Share in 2017
Table Sanofi-Aventis Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi-Aventis Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Sanofi-Aventis Biologics and Biosimilars Product
Table Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi-Aventis Biologics and Biosimilars Sales Market Share in 2017
Figure Global Sanofi-Aventis Biologics and Biosimilars Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Biologics and Biosimilars Product
Table Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Biologics and Biosimilars Sales Market Share in 2017
Figure Global Johnson & Johnson Biologics and Biosimilars Revenue Market Share in 2017
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2017)
Table Pfizer Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Pfizer Biologics and Biosimilars Product
Table Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Pfizer Biologics and Biosimilars Sales Market Share in 2017
Figure Global Pfizer Biologics and Biosimilars Revenue Market Share in 2017
Table Novo Nordisk Headquarter, Established, Main Business and Finance Overview (2017)
Table Novo Nordisk Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Novo Nordisk Biologics and Biosimilars Product
Table Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novo Nordisk Biologics and Biosimilars Sales Market Share in 2017
Figure Global Novo Nordisk Biologics and Biosimilars Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Biologics and Biosimilars Product
Table Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Biologics and Biosimilars Sales Market Share in 2017
Figure Global Eli Lilly Biologics and Biosimilars Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Novartis Biologics and Biosimilars Product
Table Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Biologics and Biosimilars Sales Market Share in 2017
Figure Global Novartis Biologics and Biosimilars Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Biologics and Biosimilars Production Bases, Sales Regions and Major Competitors
Table Merck Biologics and Biosimilars Product
Table Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Biologics and Biosimilars Sales Market Share in 2017
Figure Global Merck Biologics and Biosimilars Revenue Market Share in 2017
Table 3sbio
Table 3sbio Biologics and Biosimilars
Table Changchun High Tech
Table Changchun High Tech Biologics and Biosimilars
Table CP Guojian
Table CP Guojian Biologics and Biosimilars
Table Biotech
Table Biotech Biologics and Biosimilars
Table Gelgen
Table Gelgen Biologics and Biosimilars
Table Innovent
Table Innovent Biologics and Biosimilars
Table Dong Bao
Table Dong Bao Biologics and Biosimilars
Table Ganlee
Table Ganlee Biologics and Biosimilars
Table United Laboratories
Table United Laboratories Biologics and Biosimilars
Table Others
Table Others Biologics and Biosimilars
Table Global Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table Global Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Table Global Biologics and Biosimilars Price by Manufacturer (2016-2017)
Figure Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2017
Figure Global Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Global Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Global Biologics and Biosimilars Sales by Regions (2013-2018)
Table Global Biologics and Biosimilars Sales Market Share by Regions (2013-2018)
Table Global Biologics and Biosimilars Revenue by Regions (2013-2018)
Figure Global Biologics and Biosimilars Revenue Market Share by Regions in 2013
Figure Global Biologics and Biosimilars Revenue Market Share by Regions in 2017
Figure North America Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure North America Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Figure Europe Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Figure South America Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure South America Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Figure North America Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table North America Biologics and Biosimilars Sales by Countries (2013-2018)
Table North America Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure North America Biologics and Biosimilars Sales Market Share by Countries in 2013
Figure North America Biologics and Biosimilars Sales Market Share by Countries in 2017
Table North America Biologics and Biosimilars Revenue by Countries (2013-2018)
Table North America Biologics and Biosimilars Revenue Market Share by Countries (2013-2018)
Figure North America Biologics and Biosimilars Revenue Market Share by Countries in 2013
Figure North America Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure United States Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Canada Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Table North America Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure North America Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure North America Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table North America Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure North America Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure North America Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Table North America Biologics and Biosimilars Sales by Type (2013-2018)
Table North America Biologics and Biosimilars Sales Share by Type (2013-2018)
Table North America Biologics and Biosimilars Revenue by Type (2013-2018)
Table North America Biologics and Biosimilars Revenue Share by Type (2013-2018)
Table North America Biologics and Biosimilars Sales by Application (2013-2018)
Table North America Biologics and Biosimilars Sales Share by Application (2013-2018)
Table North America Biologics and Biosimilars Revenue by Application (2013-2018)
Table North America Biologics and Biosimilars Revenue Share by Application (2013-2018)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Europe Biologics and Biosimilars Sales by Countries (2013-2018)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Table Europe Biologics and Biosimilars Revenue by Countries (2013-2018)
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure UK Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure France Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Table Europe Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure Europe Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table Europe Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure Europe Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure Europe Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Table Europe Biologics and Biosimilars Sales by Type (2013-2018)
Table Europe Biologics and Biosimilars Sales Share by Type (2013-2018)
Table Europe Biologics and Biosimilars Revenue by Type (2013-2018)
Table Europe Biologics and Biosimilars Revenue Share by Type (2013-2018)
Table Europe Biologics and Biosimilars Sales by Application (2013-2018)
Table Europe Biologics and Biosimilars Sales Share by Application (2013-2018)
Table Europe Biologics and Biosimilars Revenue by Application (2013-2018)
Table Europe Biologics and Biosimilars Revenue Share by Application (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales by Countries (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries 2017
Table Asia-Pacific Biologics and Biosimilars Revenue by Countries (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries 2017
Figure China Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Korea Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure India Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Biologics and Biosimilars Sales by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Share by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue Share by Type (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales by Application (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Share by Application (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue by Application (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Revenue Share by Application (2013-2018)
Figure South America Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table South America Biologics and Biosimilars Sales by Countries (2013-2018)
Table South America Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure South America Biologics and Biosimilars Sales Market Share by Countries in 2017
Table South America Biologics and Biosimilars Revenue by Countries (2013-2018)
Table South America Biologics and Biosimilars Revenue Market Share by Countries (2013-2018)
Figure South America Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Argentina Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Colombia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Table South America Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure South America Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure South America Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table South America Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure South America Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure South America Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Table South America Biologics and Biosimilars Sales by Type (2013-2018)
Table South America Biologics and Biosimilars Sales Share by Type (2013-2018)
Table South America Biologics and Biosimilars Revenue by Type (2013-2018)
Table South America Biologics and Biosimilars Revenue Share by Type (2013-2018)
Table South America Biologics and Biosimilars Sales by Application (2013-2018)
Table South America Biologics and Biosimilars Sales Share by Application (2013-2018)
Table South America Biologics and Biosimilars Revenue by Application (2013-2018)
Table South America Biologics and Biosimilars Revenue Share by Application (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales by Countries (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries in 2017
Table Middle East and Africa Biologics and Biosimilars Revenue by Countries (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2013
Figure Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure UAE Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Egypt Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Nigeria Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure South Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Biologics and Biosimilars Sales by Type (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales Share by Type (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Revenue by Type (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Revenue Share by Type (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales by Application (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales Share by Application (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Revenue by Application (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Revenue Share by Application (2013-2018)
Table Global Biologics and Biosimilars Sales by Type (2013-2018)
Table Global Biologics and Biosimilars Sales Share by Type (2013-2018)
Table Global Biologics and Biosimilars Revenue by Type (2013-2018)
Table Global Biologics and Biosimilars Revenue Share by Type (2013-2018)
Figure Global Antibody Sales Growth (2013-2018)
Figure Global Antibody Price (2013-2018)
Figure Global Hormone Sales Growth (2013-2018)
Figure Global Hormone Price (2013-2018)
Figure Global Growth Factors Sales Growth (2013-2018)
Figure Global Growth Factors Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Biologics and Biosimilars Sales by Application (2013-2018)
Table Global Biologics and Biosimilars Sales Share by Application (2013-2018)
Figure Global Tumor Sales Growth (2013-2018)
Figure Global Diabetes Sales Growth (2013-2018)
Figure Global Cardiovascular Sales Growth (2013-2018)
Figure Global Hemophilia Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2018-2023)
Table Global Biologics and Biosimilars Sales Forecast by Regions (2018-2023)
Table Global Biologics and Biosimilars Market Share Forecast by Regions (2018-2023)
Figure North America Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure Europe Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure Asia-Pacific Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure South America Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure Middle East and Africa Sales Biologics and Biosimilars Market Forecast (2018-2023)
Table Global Biologics and Biosimilars Sales Forecast by Type (2018-2023)
Table Global Biologics and Biosimilars Market Share Forecast by Type (2018-2023)
Table Global Biologics and Biosimilars Sales Forecast by Application (2018-2023)
Table Global Biologics and Biosimilars Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Request a free sample Check Discount

Related Reports

Nothing-Degrading-about-Saving-Lives-E3-Ligands-Recruiting-New-Drugs

Nothing Degrading about Saving Lives: E3 Ligands Recruiting New Drugs

Report Includes: - An overview of E3 ligases, which have been long regarded as “undruggable targets”. Despite these failures both scientifically and financially, humiliations did not fully disrup ...read more

Cell-Viability-Assays-and-Consumables

Cell Viability Assays and Consumables: Global Markets

Summary Cell viability assays refer to a homogeneous method to determine the number of viable cells within a culture. Cell viability measurements are used to evaluate the effectiveness of a drug cand ...read more

Laser-Probe

Global Laser Probe Market Research Report Forecast to 2023

Introduction The laser probe is a well-known technology within the imaging industry. Formerly, these probes were used for the diagnosis of the ophthalmic disease, but nowadays these laser probes have ...read more

Myasthenia-Gravis

Global Myasthenia Gravis Market Research Report Forecast to 2023

Myasthenia Gravis Market: By Type (Ocular Myasthenia Gravis, Congenital Myasthenia Gravis, Generalized Myasthenia Gravis, Transient Myasthenia Gravis, and Others), (Diagnosis and Treatment), End User ...read more

Antihypertensive-Drugs

Global Antihypertensive Drugs Market Research Report Forecast to 2023

Antihypertensive Drugs Market Research Report: by Therapeutic Class (Calcium Channel Blockers, Beta-adrenergic Blockers, Renin Inhibitors, ACE Inhibitors, Vasodilators, Diuretics, ARBs, Others), by Ty ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.
Cards For Payment
Trusted Badge SSL Certified Premium Quality

Why Choose Us

  • Lowest Price Guarantee
    • We offer the lowest prices for the listed reports
  • Data Security
    • Your data is safe and secure
  • Vast Report Database
    • We have more than 2 Million reports in our database
  • Client Focused
    • Personalized updates and 24*7 support
  • Trusted Source and Quality
    • We only work with reputable partners providing high quality research and support
  • Market Segmentation
    • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
    • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Intel Samsung 3M BCG LEK Consulting McKinsey Thyssenkrupp Mogensen BASF IQVIA Hella Oracle Accenture Saint Gobain

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.